Dr. Martens Plc (GB:DOCS) has released an update.
In its AGM trading update, iconic British footwear brand Dr. Martens Plc announced that its performance is tracking in line with expectations, with financial projections for FY25 unchanged. The company emphasized that profits for the current year would be heavily weighted towards the second half, coinciding with the Autumn/Winter 24 season. Dr. Martens also highlighted ongoing cost management efforts and the aim for direct-to-consumer growth in the US market, with more details to be shared in the November earnings update.
For further insights into GB:DOCS stock, check out TipRanks’ Stock Analysis page.
